Boehringer In­gel­heim beefs up vet port­fo­lio with GST buy­out; No­var­tis, Aus­tria to in­vest €150M in Eu­ro­pean man­u­fac­tur­ing deal

One year af­ter the Eu­ro­pean launch of Ar­ti-Cell Forte — a stem cell prod­uct used to treat lame­ness in hors­es — Boehringer In­gel­heim has ac­quired Bel­gian vet­eri­nary …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER